Best Longevity Podcasts 2026

The Peter Attia Drive

Weekly

Dr. Peter Attia goes deeper on longevity science than anyone else in media. Rigorous, evidence-based, and laser-focused on extending healthspan.

→ WHAT IT COVERS Reproductive medicine specialist Renato Tomioka explains endometriosis and adenomyosis — conditions affecting 10% and 20–30% of women

Huberman Lab

2x/week

Stanford neuroscientist Andrew Huberman turns peer-reviewed research into actionable protocols for sleep, focus, exercise, and stress.

→ WHAT IT COVERS Dr. Paul Eastwick, psychology professor at UC Davis, presents data from speed dating studies, longitudinal relationship research, and

10% Happier with Dan Harris

3x/week

Former ABC anchor Dan Harris makes meditation accessible for skeptics. Practical, science-backed mindfulness without the woo.

→ WHAT IT COVERS Oncologist and bioethicist Dr. Ezekiel Emanuel presents six evidence-based rules for longevity from his book Eat Your Ice Cream , ar

The Rich Roll Podcast

Weekly

Ultra-endurance athlete Rich Roll hosts wide-ranging conversations on plant-based living, mental health, and what it means to live with purpose.

→ WHAT IT COVERS Radiohead guitarist Ed O'Brien speaks with Rich Roll about navigating a prolonged depression during COVID lockdown, tracing its roots

Citeline Podcasts

Daily

Industry intelligence on clinical trials, regulatory trends, and pharma strategy from Citeline's expert analysts.

→ WHAT IT COVERS Generics Bulletin editors report from two February 2026 industry conferences — AAM's Access meeting in Miami and Medicines for Europe

Mind Pump: Raw Fitness Truth

Daily

Sal Di Stefano and the Mind Pump crew cut through fitness industry BS with evidence-based training advice and entertaining banter.

→ WHAT IT COVERS Sal DiStefano, Adam Schafer, and Justin Andrews break down why fat burner supplements deliver zero measurable fat loss, which supplem

Beyond Biotech

Weekly

Labiotech.eu's official podcast — broad global coverage of biotech news, partnerships, and emerging therapies. Great for a European perspective on drug development.

→ WHAT IT COVERS Werner Lanthaler, former Evotec CEO who scaled the company from 200 employees and €40M to 5,000 staff and €800M revenue, shares pract

ZOE Science & Nutrition

2x/week

Tim Spector and the ZOE team break down nutrition science with real data. Personalized health backed by the largest nutrition study ever.

→ WHAT IT COVERS Professor Tim Spector breaks down carbohydrates into simple sugars, starches, and fibers, explaining why eliminating all carbs is mis

The Doctor's Farmacy

2x/week

Dr. Mark Hyman explores functional medicine, root-cause health, and the food-as-medicine movement. Challenges mainstream nutrition dogma.

→ WHAT IT COVERS Relationship repair expert Baya Voce joins Dr. Mark Hyman to explain why modern relationships fail not from too much conflict, but fr

The Long Run with Luke Timmerman

Biweekly

Veteran biotech journalist Luke Timmerman goes deep with CEOs, VCs, and scientists. Thoughtful long-form interviews that reveal the people and strategies behind biotech companies.

→ WHAT IT COVERS Sri Kosuri, cofounder and CEO of Octant Bio, describes how the company builds oral small molecule correctors targeting protein misfol

The Model Health Show

Shawn Stevenson

2x/week

Shawn Stevenson breaks down the science of sleep, nutrition, and exercise with an emphasis on practical protocols and metabolic health.

→ WHAT IT COVERS Jimmy Choi, diagnosed with early-onset Parkinson's disease at 27, shares how he went from 250 pounds and using a cane to completing 1

Biotech Hangout

Weekly

Friday roundtable with Daphne Zohar, Brad Loncar, and rotating guests. Fast-paced weekly recap of biotech news, deals, and FDA actions — like a biotech happy hour with insiders.

→ WHAT IT COVERS Biotech Hangout Episode 186 covers mid-2026 biotech market performance, with XBI up 10.5% year-to-date, a record $771M Parabolas IPO,

Feel Better, Live More

2x/week

Dr. Rangan Chatterjee helps listeners feel better through small, sustainable changes to sleep, movement, food, and relaxation. Evidence-based and compassionate.

→ WHAT IT COVERS Dr. Tommy Wood, neuroscientist and Formula One performance coach, presents evidence that 45–70% of dementia cases are preventable usi

BioCentury This Week

Weekly

The gold standard for weekly biotech industry analysis. BioCentury's editorial team breaks down deals, clinical data, and regulatory moves with investor-grade rigor.

→ WHAT IT COVERS BioCentury This Week examines biotech capital markets momentum amid geopolitical uncertainty, Xenon Pharmaceuticals' phase three epil

The Proof

Weekly

Simon Hill examines nutrition claims through the lens of published research. Evidence over opinion — the most scientifically rigorous nutrition podcast.

→ WHAT IT COVERS Stanford professor Christopher Gardner, who served on the 2025 Dietary Guidelines Advisory Committee, and GAIN nutrition scientist Ty

Business Of Biotech

Weekly

Ben Comer (Life Science Leader) interviews biotech CEOs on the operational realities of building a drug company — from fundraising to commercialization.

→ WHAT IT COVERS Marc Hedrick, CEO of Plus Therapeutics, details the development of Rhenium-186 radiotherapeutic Rayovik for CNS cancers including gli

The Genius Life

Weekly

Max Lugavere covers brain health, nutrition, and cognitive performance with the latest research. Practical protocols for mental sharpness.

→ WHAT IT COVERS Dave Evans, cofounder of the Stanford Life Design Lab and coauthor of Designing Your Life , applies design thinking principles to me

The Readout Loud

Weekly

STAT News' weekly biotech podcast — breaks down clinical trial results, FDA policy shifts, and industry deals. The newsroom perspective that biotech investors trust.

→ WHAT IT COVERS This episode covers three biotech stories: Vinay Prasad's second departure from the FDA and its impact on rare disease drug approvals

The RTW Podcast

Monthly

Real-time commentary on biotech investing trends, clinical data readouts, and sector dynamics from an investment research perspective.

→ WHAT IT COVERS Rod Wong, founder and CIO of RTW Investments, traces biotech's evolution from the 2000 Human Genome Project through today's commercia

The Bio Report

Weekly

Award-winning biotech journalist Daniel Levine covers where biotechnology meets business, policy, and science. Concise, well-researched episodes for busy professionals.

→ WHAT IT COVERS Immuneering CEO Ben Zeskind explains how the company's informatics-driven "deep cyclic inhibition" approach to MEK inhibition deliver

The WHOOP Podcast

Weekly

WHOOP's podcast covers the science of recovery, strain, and sleep optimization with real athlete data and expert guests.

→ WHAT IT COVERS Dr. Trishan Panch, physician-entrepreneur and Harvard School of Public Health faculty, examines how AI and wearables are filling the

The Life Science Rundown

Biweekly

Quick daily briefings on the latest in drug development, clinical trials, and life science news. Built for biopharma professionals.

→ WHAT IT COVERS Cary Smithson of Leap Ahead Solutions outlines how life science companies must establish structured data governance frameworks to mee

Pathfinders in Biopharma

Biweekly

Biopharma leaders share how they navigated the path from discovery to commercialization. Hard-won lessons from drug development veterans.

→ WHAT IT COVERS RBC Capital Markets analyst Brian Abrams assesses biotech's 80% rally from April 2025 lows, evaluating whether sector momentum can pe

Biotech Bulls & Breakthroughs

Monthly

Focused on small-cap and mid-cap biotech catalysts — phase 3 data readouts, FDA decisions, and the binary events that move stocks. Essential for biotech investors.

→ WHAT IT COVERS Biotech trader Jeff "Chef" reviews how the FDA's one-pivotal-trial rule produced a landmark win for Outlook Therapeutics (OTLK), then

Biotech 2050 Podcast

Monthly

Forward-looking conversations on where biotech is headed — gene therapy, synthetic biology, and the next-gen platform technologies reshaping drug discovery.

→ WHAT IT COVERS Adial Pharmaceuticals CEO Cary Claiborne explains how AD04, a repurposed low-dose ondansetron, targets a specific genetic biomarker f

Found My Fitness

Monthly

Dr. Rhonda Patrick dives deep into the molecular mechanisms of nutrition, aging, and human performance. PhD-level science made actionable.

→ WHAT IT COVERS Dr. Charles Brenner, discoverer of nicotinamide riboside, explains NAD biology and its role in cellular energy, DNA repair, and infla

Drug Story

Monthly

Deep dives into the stories behind breakthrough drugs — how they were discovered, developed, and brought to patients. Narrative-driven and accessible to non-specialists.

→ WHAT IT COVERS Tim Harford traces the rise of Lydia Pinkham's Vegetable Compound, a 20% alcohol herbal tonic marketed to women in the 1870s-1900s, e